Point-of-Care Test Component

Gembloux, Belgium

e-Proteins is a Belgium-based biotechnology company pioneering next-generation biotin-binding proteins and conjugation technologies for advanced diagnostic applications. Its engineered protein portfolio — including HookDin®, NeutraliteAvidin®, and BBS® — enables superior assay sensitivity, dynamic range, and stability in Lateral Flow Assays (LFA) , ELISA , and biosensor platforms. By addressing key limitations such as the high-dose hook effect and suboptimal conjugation efficiency, e-Proteins technologies deliver consistent, high-performance results across gold- and latex-based nanoparticle systems. The company collaborates globally with diagnostic and life-science partners to integrate its proprietary reagents into cutting-edge products and platforms. Through custom conjugation, assay optimization, and licensing , e-Proteins empowers developers to accelerate innovation and achieve reproducible, reliable diagnostic performance. Driven by molecular precision and practical impact, e-Proteins is redefining how protein engineering advances the sensitivity and robustness of today s and tomorrow s diagnostic assays.